The FDA has had a busy month, overseeing the recall of nearly 88,000 implantable cardiac devices, juggling the continued rise of monkeypox cases in the United States and maintaining an active Breakthrough Devices program. This rundown covers some of the agency's biggest moves during that time. 

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

Thinking has changed: Cardiac implantable electronic device (CIED) infections are a bigger deal than we thought.

The news comes after the Onyx Frontier DES gained CE mark approval. It received FDA approval in May.

Overall, PCI patients appear to face a higher risk of in-hospital mortality, 30-day mortality and in-hospital cardiovascular mortality if they present with an active or historical cancer diagnosis. The group's analysis included data from nearly 6.6 million patients.

The National Heart, Lung and Blood Institute, part of the National Institutes of Health, awarded the funds to three research teams. 

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022. 

A new AI tool from Washington University in St. Louis researchers aims to help identify burnout among physicians and could potentially prevent it in the future.